Bezafibrate stimulates canalicular localization of NBD-labeled PC in HepG2 cells by PPARalpha-mediated redistribution of ABCB4.
about
Recent advances in understanding and managing cholestasisClinical application of transcriptional activators of bile salt transporters.Fibrates for the treatment of cholestatic itch (FITCH): study protocol for a randomized controlled trial.Peroxisome proliferator-activated receptor α activates human multidrug resistance transporter 3/ATP-binding cassette protein subfamily B4 transcription and increases rat biliary phosphatidylcholine secretionFibrates and cholestasisNuclear receptors as drug targets in cholestatic liver diseases.Nuclear receptors as therapeutic targets in cholestatic liver diseases.The state of cholesterol metabolism in the liver of patients with primary biliary cirrhosis: the role of MDR3 expression.The Multiple Facets of ABCB4 (MDR3) DeficiencyA human hepatocyte-bearing mouse: an animal model to predict drug metabolism and effectiveness in humansTargeting the ABCB4 gene to control cholesterol homeostasis.Bile acid transporters and regulatory nuclear receptors in the liver and beyondMolecular mechanisms for biliary phospholipid and drug efflux mediated by ABCB4 and bile saltsJunctional adhesion molecule-A is critical for the formation of pseudocanaliculi and modulates E-cadherin expression in hepatic cells.PPAR Medicines and Human Disease: The ABCs of It All.Peroxisome proliferator-activated receptor α positively regulates complement C3 expression but inhibits tumor necrosis factor α-mediated activation of C3 gene in mammalian hepatic-derived cells.Thyroid hormone receptor β1 stimulates to increase biliary phosphatidylcholine excretion in micePathophysiological analysis of primary biliary cirrhosis focusing on choline/phospholipid metabolism
P2860
Q26748537-7B8324E6-9AC7-4B1B-8B49-19AA15ECBA70Q33709930-51AF97DF-7A19-40BD-9CE2-BA2DC828B313Q33721771-995A61EB-1DD2-4E17-BC1E-62D82945448DQ33725965-B54F7F5E-036B-4439-8C28-D04457A4DBB6Q35889448-C7ADD497-4CD5-4BCC-A64C-44BA6787194BQ36786270-E198D6C7-7111-4F32-A7F2-5E73E18D6AE1Q37230857-B93EB623-B202-42E8-984B-23F8BCECFC88Q37356791-BF7AE312-5276-489D-9D17-7A9F36917EDFQ37464242-AC2DEA02-9895-4687-88FA-3CD8A9D04646Q37626434-86A8E7BA-93DA-48C0-9E90-D03B99FA6F60Q37908143-4D76CCBD-BE86-4E1A-8294-73AEC902A53FQ38033967-34B85DB2-1685-444A-B780-BDEB1E219672Q38240898-42391965-B2FF-4C00-A943-B4709C8B634AQ40108852-D723318E-6342-47C3-A5BB-2C145BEB3BD9Q42214835-CB7C666F-BF28-4FF7-942E-E3D016DC8A36Q42798325-413708A1-5983-441D-8A58-29A8DD61AE80Q57109925-8CB94034-32B2-4DC8-AD86-A6E799F82930Q57146469-DBDDA900-6428-4042-82D1-C684EA9AE6D4
P2860
Bezafibrate stimulates canalicular localization of NBD-labeled PC in HepG2 cells by PPARalpha-mediated redistribution of ABCB4.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Bezafibrate stimulates canalic ...... iated redistribution of ABCB4.
@ast
Bezafibrate stimulates canalic ...... iated redistribution of ABCB4.
@en
type
label
Bezafibrate stimulates canalic ...... iated redistribution of ABCB4.
@ast
Bezafibrate stimulates canalic ...... iated redistribution of ABCB4.
@en
prefLabel
Bezafibrate stimulates canalic ...... iated redistribution of ABCB4.
@ast
Bezafibrate stimulates canalic ...... iated redistribution of ABCB4.
@en
P2093
P2860
P1476
Bezafibrate stimulates canalic ...... iated redistribution of ABCB4.
@en
P2093
Atsutoshi Tsuji
David E Cohen
Hiroshi Kusama
Hiroshi Suzuki
Junichi Shoda
Naomi Tanaka
Tadashi Ikegami
Tetsuya Ueda
Yoichi Inada
Yuichi Sugiyama
P2860
P304
P356
10.1194/JLR.M400132-JLR200
P577
2004-07-16T00:00:00Z